Division of Pediatric Nephrology,, †Montefiore-Einstein Center for Transplantation,, ‡Department of Pathology,, §Computational Genomics Facility, Department of Genetics, and, ‖Division of Nephrology, Albert Einstein College of Medicine, Bronx, New York.
Clin J Am Soc Nephrol. 2013 Dec;8(12):2141-8. doi: 10.2215/CJN.04240413. Epub 2013 Sep 12.
This study investigated the mechanisms involved in development of donor-specific antibody (DSA) and/or C4d-negative transplant glomerulopathy (TGP) by allograft gene expression profiles using microarrays.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cohort study was conducted in kidney transplant recipients. Patients were eligible for inclusion if they required a clinically indicated biopsy at any time point after their transplant. They were then classified according to their histopathology findings and DSA and C4d results. Eighteen chronic antibody-mediated rejection (CAMR), 14 DSA+/C4d- TGP, 25 DSA-/C4d- TGP, and 47 nonspecific interstitial fibrosis/tubular atrophy (IFTA) biopsy specimens were identified. In a subset of patients from the study population, biopsy specimens in each group and normal transplant kidney specimens were analyzed with Affymetrix Human Gene 1.0 ST Arrays.
The mean sum score of glomerulitis and peritubular capillaritis increased from 0.28±0.78 in IFTA specimens to 0.75±0.85 in DSA-/C4d- TGP specimens, 1.71±1.49 in DSA+/C4d-/TGP specimens, and 2.11±1.74 in CAMR specimens (P<0.001). During a median follow-up time of 2 (interquartile range, 1.4-2.8) years after biopsy, graft loss was highest in CAMR specimens (27.8%) compared to IFTA specimens (8.5%), DSA+/C4d- TGP specimens (14.3%), and DSA-/C4d- TGP specimens (16%) (P=0.01). With use of microarrays, comparison of the gene expression profiles of DSA-/C4d- TGP specimens with glomerulitis + peritubular capillaritis scores > 0 to normal and IFTA biopsy specimens revealed higher expression of quantitative cytotoxic T cell-associated transcripts (QCAT). However, both CAMR and DSA+/C4d- TGP specimens had higher expression of not only QCAT but also IFN-γ and rejection-induced, constitutive macrophage-associated, natural killer cell-associated, and DSA-selective transcripts. Endothelial cell-associated transcript expression was upregulated only in CAMR biopsy specimens.
These results suggested that DSA+/C4d- TGP biopsy specimens may be classified as CAMR. In contrast, DSA-/C4d- TGP specimens showed increased cytotoxic T cell-associated transcripts, suggesting T cell activation as a mechanism of injury.
本研究通过基因芯片分析同种异体移植基因表达谱,探讨了供体特异性抗体(DSA)和/或 C4d 阴性移植肾小球病(TGP)的发病机制。
设计、地点、参与者和测量:本队列研究在肾移植受者中进行。如果患者在移植后任何时间点需要进行临床指征的活检,则有资格入组。然后根据其组织病理学发现以及 DSA 和 C4d 结果进行分类。18 例慢性抗体介导的排斥反应(CAMR)、14 例 DSA+/C4d-TGP、25 例 DSA-/C4d-TGP 和 47 例非特异性间质纤维化/肾小管萎缩(IFTA)活检标本被确定。在研究人群中的一部分患者中,对每个组的活检标本和正常移植肾标本进行了 Affymetrix Human Gene 1.0 ST Arrays 分析。
肾小球炎和肾小管周围毛细血管炎的平均总评分从 IFTA 标本的 0.28±0.78 增加到 DSA-/C4d-TGP 标本的 0.75±0.85、DSA+/C4d-TGP 标本的 1.71±1.49 和 CAMR 标本的 2.11±1.74(P<0.001)。在活检后中位数为 2(四分位距,1.4-2.8)年的中位随访期间,CAMR 标本的移植物丢失率最高(27.8%),与 IFTA 标本(8.5%)、DSA+/C4d-TGP 标本(14.3%)和 DSA-/C4d-TGP 标本(16%)相比(P=0.01)。使用微阵列,将 DSA-/C4d-TGP 标本的基因表达谱与肾小球炎+肾小管周围毛细血管炎评分>0与正常和 IFTA 活检标本进行比较,发现定量细胞毒性 T 细胞相关转录物(QCAT)的表达更高。然而,CAMR 和 DSA+/C4d-TGP 标本不仅表达更高的 QCAT,还表达更高的 IFN-γ 和诱导排斥的、组成性巨噬细胞相关的、自然杀伤细胞相关的和 DSA 选择性转录物。仅在 CAMR 活检标本中观察到内皮细胞相关转录物的表达上调。
这些结果表明,DSA+/C4d-TGP 活检标本可能被归类为 CAMR。相比之下,DSA-/C4d-TGP 标本显示出细胞毒性 T 细胞相关转录物增加,提示 T 细胞激活是损伤的机制之一。